Mallick Parag, Chief Scientist at Nautilus Biotechnology Inc. ($NAUT), bought shares on the open market twice in the last year for a total of $9,885, with his most recent purchase on May 12, 2025. His activity ranks 4,337th out of 4,983 insiders, well below the average purchase of $1.46 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Nautilus Biotechnology, Inc. | $NAUT | Mallick Parag | Chief Scientist | A | Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 126,305,122 | 9999.99% | 0.22% |
| May 8, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Mallick Parag | Chief Scientist | P | Common Stock | 12000 | $0.73 | 20,491,892.0000 | 126,148,469 | 0.06% | 0.01% |
| May 12, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Mallick Parag | Chief Scientist | P | Common Stock | 1500 | $0.73 | 20,493,392.0000 | 126,148,469 | 0.01% | 0.00% |
| March 3, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Mallick Parag | Chief Scientist | A | Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 126,148,469 | 9999.99% | 0.22% |
| March 1, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Mallick Parag | Chief Scientist | A | Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2023 | Nautilus Biotechnology, Inc. | $NAUT | Mallick Parag | Chief Scientist | A | Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 0 | 9999.99% | 0.00% |